URINARY METABOLITES OF PINACIDIL .2. SPECIES-DIFFERENCE IN THE METABOLISM OF PINACIDIL

被引:8
作者
SAKAMOTO, K
NAKAMURA, Y
机构
[1] Kanzakigawa Laboratory, Shionogi Research Laboratories, Shionogi and Co. Ltd., Toyonaka, Osaka 561
关键词
D O I
10.3109/00498259309059402
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Pinacidil was given orally to rabbit (10 mg/kg), dog (10 mg/kg), monkey (10 mg/kg) and mouse (150 mg/kg), the urinary metabolites were separated by h.p.l.c. and their structures determined by mass spectrometry, 2. Three new metabolites, namely, omega-hydroxy-pinacidil-O-glucuronide (M-8), pinacidil-pyridine-N-oxide-O-glucuronide (M-9) and pinacidil-pyridine-N-glucuronide (M-10) were isolated from rabbit urine, and one new metabolite, namely, pinacidil-pyridine-phenolic-glucuronide (M-11) was isolated from mouse urine. 3. M-9 is a unique glucuronide because the glucuronic acid is linked to the oxygen of pyridine-N-oxide. 4. In man, similar to rat, dog and mouse, pinacidil-pyridine-N-oxide (M-1) was the main urinary metabolite, with pyridine-N-oxidation being the major metabolic pathway. On the other hand, M-8 and M-9 were the most abundant metabolites in monkey and rabbit urine, respectively. Therefore, rat, dog and mouse have similar metabolism of pinacidil to man, but monkey and rabbit are significantly different in their metabolism of the drug.
引用
收藏
页码:649 / 656
页数:8
相关论文
共 10 条
[1]   N''-CYANO-N-4-PYRIDYL-N'-1,2,2-TRIMETHYLPROPYLGUANIDINE, MONOHYDRATE (P 1134) - A NEW, POTENT VASODILATOR [J].
ARRIGONIMARTELLI, E ;
NIELSEN, CK ;
OLSEN, UB ;
PETERSEN, HJ .
EXPERIENTIA, 1980, 36 (04) :445-447
[2]   PREPARATION AND HYDROLYSIS OF N-GLUCURONIDES OF PYRIDINE AND PIPERIDINE [J].
DALGAARD, L .
ACTA CHEMICA SCANDINAVICA SERIES B-ORGANIC CHEMISTRY AND BIOCHEMISTRY, 1983, 37 (10) :923-928
[3]   DISPOSITION OF [C-14] PINACIDIL IN HUMANS [J].
DELONG, AF ;
OLDHAM, SW ;
DESANTE, KA ;
NELL, G ;
HENRY, DP .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (02) :153-156
[4]   METABOLISM OF THE NEW ANTIHYPERTENSIVE AGENT PINACIDIL IN RAT, DOG AND MAN [J].
EILERTSEN, E ;
MAGNUSSEN, MP ;
PETERSEN, HJ ;
RASTRUPANDERSEN, N ;
SORENSEN, H ;
ARRIGONIMARTELLI, E .
XENOBIOTICA, 1982, 12 (03) :187-196
[5]   N''-CYANO-N-4-PYRIDYL-N'-1,2,2-TRIMETHYL-PROPYLGUANIDINE, A NEW VASODILATING AGENT - ACUTE EFFECT ON BLOOD-PRESSURE AND PHARMACOKINETICS IN HYPERTENSIVE PATIENTS [J].
KARDEL, T ;
HILDEN, T ;
CARLSEN, J ;
TRAPJENSEN, J .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1981, 3 (05) :1002-1007
[6]   SYNTHESIS AND HYPOTENSIVE ACTIVITY OF N-ALKYL-N'-CYANO-N'-PYRIDYLGUANIDINES [J].
PETERSEN, HJ ;
NIELSEN, CK ;
ARRIGONIMARTELLI, E .
JOURNAL OF MEDICINAL CHEMISTRY, 1978, 21 (08) :773-781
[7]  
RUBIN A, 1979, DRUG METAB DISPOS, V7, P149
[8]  
SAKAMOTO K, 1993, UNPUB XENOBIOTICA
[9]   METABOLISM OF MINOXIDIL, A NEW HYPOTENSIVE AGENT .2. BIOTRANSFORMATION FOLLOWING ORAL-ADMINISTRATION TO RATS, DOGS, AND MONKEYS [J].
THOMAS, RC ;
HARPOOTLIAN, H .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (08) :1366-1371
[10]   INVITRO STUDIES ON THE MODE OF ACTION OF PINACIDIL [J].
WESTON, AH ;
BRAY, KM ;
DUTY, S ;
MCHARG, AD ;
NEWGREEN, DT ;
SOUTHERTON, JS .
DRUGS, 1988, 36 :10-28